Key result
Atrial natriuretic peptide reduces the secretion of inflammatory mediators such as iNOS and TNF-alpha in macrophages, suggesting it possesses anti-inflammatory potential.
Why the study?
Does atrial natriuretic peptide reduce the production of inflammatory mediators in macrophages?
Population
Macrophages and human whole blood
Design
Review
Authors
Loading...
ANP's anti-inflammatory macrophage effects merit exploration in cardiovascular inflammation; hypothesis-generating without clinical validation.
Does atrial natriuretic peptide reduce the production of inflammatory mediators in macrophages?
ANP demonstrates anti-inflammatory potential by reducing the secretion of pro-inflammatory mediators in macrophages.
Kiemer et al. (2001) conducted a review in Inflammation. Atrial natriuretic peptide (ANP) was evaluated. Atrial natriuretic peptide reduces the secretion of inflammatory mediators such as iNOS and TNF-alpha in macrophages, suggesting it possesses anti-inflammatory potential.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: